Liposome with oligosaccharide on surface
US5759572A · kind A · utility
21Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 1995 |
| Grant date | Jun 2, 1998 |
| Priority date | — |
| Expiry date | Sep 18, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/6911
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are provided liposomes as an adjuvant which is effective for cellular immunity, has low toxicity and antigenicity, and may be administered to humans. The liposomes have oligosaccharide on their surface which consists of 2 to 11 saccharide residues and binds to lectin of antigen presenting cells. A vaccine may be prepared by reconstituting an antigen into the liposomes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.